Join the U.S. Commercial Service to get the insight you need to move confidently into Australia!
Are you considering doing clinical trials in Australia? Finding partners for co-development? Looking to possibly sell your products into Australia either now or in the future? This is the trip you NEED to take!
WHY Australia?
Australia is the leading location for biotechnology companies in the Asia-Pacific with over 1,000 biotechnology companies
Australia’s US$11.39bn pharmaceutical market is among the five largest in the Asia Pacific region. Australia has the region’s second highest annual spending on medicine, after Japan.
According to UN Comtrade, Australia imported finished medicine worth US$7.1bn in 2010.
Our team of Australian experts will help guide you to be successful in the booming Australian biotech market. During the trip you will have the opportunity to:
- Attend U.S. Consulate briefings on “Doing Business in Australia”
- Network with major players in Australia’s Life Science Industry
- Receive a Legal Briefing on “Contracts” and “Protecting Your Intellectual Property”
- Meet Australian Government Officials
- Attend the AusBiotech Annual Biotech Conference and Explore Potential Business Opportunities
- Attend site visit in Melbourne, getting a first-hand look at the life sciences industry in Australia
Mission Schedule:
Oct. 29 Arrive Melbourne
Group Dinner
Oct. 30 Australia Market Briefing
Site Visit
Networking Lunch & Biotech Briefing
Networking Reception
Oct. 31 AusBiotech National Conference 2012
BioPartnering Business Matchmaking
Conference Welcome Reception
Nov. 1 AusBiotech National Conference 2012
BioPartnering Business Matchmaking
Conference Dinner
Nov. 2 AusBiotech National Conference 2012
BioPartnering Business Matchmaking
Conference Closing Reception
Cost: $4,504 for small or medium-sized enterprises (SME); $5,321 for large companies.
For more information, please contact:
Gabriela Zelaya
International Trade Specialist
408-535-2757, ext. 107
Aileen Nandi
Senior Commercial Officer
408-535-2757, ext. 102